{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:22:47Z","timestamp":1790277767361,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.xphs.2020.10.033","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T02:45:22Z","timestamp":1603334722000},"page":"1676-1686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Freeze-Dried Matrices for Buccal Administration of Propranolol in Children: Physico-Chemical and Functional Characterization"],"prefix":"10.1016","volume":"110","author":[{"given":"Angela","family":"Abruzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Crispini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Adduci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiore Pasquale","family":"Nicoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cerchiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bigucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2020.10.033_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.msec.2017.12.022","article-title":"An overview of polymeric dosage forms in buccal drug delivery: state of art, design of formulations and their in\u00a0vivo performance evaluation","volume":"86","author":"Fonseca","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.xphs.2020.10.033_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijpharm.2014.05.043","article-title":"Oral transmucosal drug delivery-current status and future prospects","volume":"471","author":"Sattar","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.04.012","article-title":"Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs","volume":"114","author":"Sudhakar","year":"2006","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.xphs.2020.10.033_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/17425247.2.3.507","article-title":"Buccal drug delivery","volume":"2","author":"Smart","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2020.10.033_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijpharm.2017.07.017","article-title":"Patient acceptability, safety and access: a balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations","volume":"536","author":"Walsh","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2013.08.011","article-title":"Oral transmucosal drug delivery for pediatric use","volume":"73","author":"Lam","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2020.10.033_bib7","doi-asserted-by":"crossref","first-page":"119293","DOI":"10.1016\/j.ijpharm.2020.119293","article-title":"Development and evaluation of mucoadhesive buccal dosage forms of lidocaine hydrochloride by ex-vivo permeation studies","volume":"581","author":"Kottke","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib8","doi-asserted-by":"crossref","first-page":"119228","DOI":"10.1016\/j.ijpharm.2020.119228","article-title":"Ondansetron buccal administration for paediatric use: a comparison between films and wafers","volume":"580","author":"Giordani","year":"2020","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.10.033_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/polym10020157","article-title":"Effects of cyclodextrins (\u03b2 and \u03b3) and l-Arginine on stability and functional properties of mucoadhesive buccal films loaded with omeprazole for pediatric patients","volume":"10","author":"Khan","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.xphs.2020.10.033_bib10","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1016\/j.xphs.2017.07.009","article-title":"Drug delivery innovations to address global health challenges for pediatric and geriatric populations (through improvements in patient compliance)","volume":"106","author":"Boateng","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1208\/s12249-014-0243-3","article-title":"Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in\u00a0vitro evaluation","volume":"16","author":"Kassem","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.10.033_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.xphs.2020.10.033_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/17425247.2016.1198767","article-title":"Application of freeze-drying in the development of oral drug delivery systems","volume":"13","author":"Siow","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2020.10.033_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2014.04.017","article-title":"An improved cryopreservation method for porcine buccal mucosa in ex\u00a0vivo drug permeation studies using Franz diffusion cells","volume":"60","author":"Amores","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02976701","article-title":"Enhanced ex\u00a0vivo buccal transport of propranolol: evaluation of phospholipids as permeation enhancers","volume":"26","author":"Lee","year":"2003","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.xphs.2020.10.033_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/j.1552-4604.1993.tb04720.x","article-title":"The hepatic first-pass metabolism of problematic drugs","volume":"33","author":"Lalka","year":"1993","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.xphs.2020.10.033_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4330\/wjc.v6.i5.234","article-title":"Anti-hypertensive drugs in children and adolescents","volume":"6","author":"Chu","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.xphs.2020.10.033_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.msec.2018.12.036","article-title":"Design and optimization of kollicoat \u00ae IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride","volume":"97","author":"Salehi","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.xphs.2020.10.033_bib19","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1002\/jps.24688","article-title":"Mucoadhesive buccal tablets based on chitosan\/gelatin microparticles for delivery of propranolol hydrochloride","volume":"104","author":"Abruzzo","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.carbpol.2011.08.024","article-title":"Mucoadhesive chitosan\/gelatin films for buccal delivery of propranolol hydrochloride","volume":"87","author":"Abruzzo","year":"2012","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2020.10.033_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpharm.2008.03.005","article-title":"Formulation of monolayered films with drug and polymers of opposing solubilities","volume":"358","author":"Perumal","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03639040701539842","article-title":"Comparing the mucoadhesivity and drug release mechanisms of various polymer-containing propranolol buccal tablets","volume":"34","author":"Munasur","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib23","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1208\/pt0803077","article-title":"Mucoadhesive bilayer tablets of propranolol hydrochloride","volume":"8","author":"Patel","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.10.033_bib24","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1208\/pt0802045","article-title":"Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design","volume":"8","author":"Patel","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.10.033_bib25","doi-asserted-by":"crossref","first-page":"E147","DOI":"10.1208\/pt0801022","article-title":"Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride","volume":"8","author":"Patel","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.10.033_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpharm.2017.08.070","article-title":"Bilayered buccal films as child-appropriate dosage form for systemic administration of propranolol","volume":"531","author":"Abruzzo","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2018.04.041","article-title":"Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics","volume":"120","author":"Freag","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2015.06.022","article-title":"Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: development and characterization","volume":"492","author":"Hazzah","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/03639045.2014.925914","article-title":"Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrocloride","volume":"41","author":"Bigucci","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolut Technol"},{"key":"10.1016\/j.xphs.2020.10.033_bib31","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/jps.20409","article-title":"Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue","volume":"94","author":"Diaz del Consuelo","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib32","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1208\/s12249-017-0754-9","article-title":"Microemulsion-based mucoadhesive buccal wafers: wafer formation, in\u00a0vitro release, and ex\u00a0vivo evaluation","volume":"18","author":"Pham","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.10.033_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.archoralbio.2005.04.008","article-title":"Comparison of the lipid composition of porcine buccal and esophageal permeability barriers","volume":"50","author":"Diaz del Consuelo","year":"2005","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.xphs.2020.10.033_bib34","doi-asserted-by":"crossref","first-page":"1281673","DOI":"10.1155\/2018\/1281673","article-title":"The influence of formulation and excipients on propranolol skin permeation and retention","volume":"2018","author":"Padula","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xphs.2020.10.033_bib35","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.tiv.2008.03.008","article-title":"Expression of procollagen alpha1 type I and tenascin proteins induced by HEMA in human pulp fibroblasts","volume":"22","author":"Zago","year":"2008","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"5","key":"10.1016\/j.xphs.2020.10.033_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejps.2009.09.003","article-title":"Multiple approaches to pharmaceutical polymorphism investigation-a case study","volume":"38","author":"Li","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0731-7085(99)00128-4","article-title":"Physico-chemical characterisation of the modifications I and II of (R,S) propranolol hydrochloride: solubility and dissolution studies","volume":"21","author":"Bartolomei","year":"1999","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2020.10.033_bib38","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/jps.21943","article-title":"The binary phase diagram of propranolol hydrochloride and crystallization-based enantioseparation","volume":"99","author":"Polenske","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2020.10.033_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.xphs.2020.10.033_bib40","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jps.20918","article-title":"Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility","volume":"96","author":"Bhugra","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2017.05.012","article-title":"Chitosan-clay nanocomposite microparticles for controlled drug delivery: effects of the MAS content and TPP crosslinking","volume":"40","author":"Khlibsuwan","year":"2017","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2020.10.033_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1081\/PDT-100100555","article-title":"In situ gel formulations for gene delivery: release and myotoxicity studies","volume":"5","author":"Ismail","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2020.10.033_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejps.2008.09.004","article-title":"Chitosan\/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin","volume":"35","author":"Bigucci","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0939-6411(03)00161-9","article-title":"Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications","volume":"57","author":"Berger","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/03639045.2011.598536","article-title":"Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts","volume":"38","author":"Bertram","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib46","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.addr.2005.07.003","article-title":"The use of mucoadhesive polymers in buccal drug delivery","volume":"57","author":"Salamat-Miller","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2020.10.033_bib47","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.xphs.2020.10.033_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.carbpol.2009.07.018","article-title":"Study on the mucoadhesion mechanism of pectin by atomic force microscopy and mucin-particle method","volume":"79","author":"Sriamornsak","year":"2010","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2020.10.033_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jddst.2015.06.016","article-title":"A\u00a0focus on mucoadhesive polymers and their application in buccal dosage forms","volume":"32","author":"Russo","year":"2016","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2020.10.033_bib50","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G","article-title":"Bioadhesive-based dosage forms: the next generation","volume":"89","author":"Lee","year":"2000","journal-title":"J\u00a0Pharm Sci"},{"issue":"2-3","key":"10.1016\/j.xphs.2020.10.033_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","article-title":"Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2020.10.033_bib52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1023\/A:1018914301328","article-title":"HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics","volume":"16","author":"Siepmann","year":"1999","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.xphs.2020.10.033_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.carbpol.2006.07.028","article-title":"Development of chitosan sponges for buccal administration of insulin","volume":"68","author":"Portero","year":"2007","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2020.10.033_bib54","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0142-9612(00)00134-4","article-title":"Enhancing effect of chitosan on peptide drug delivery across buccal mucosa","volume":"21","author":"\u015eenel","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2020.10.033_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03639045.2012.743559","article-title":"Formulation study of a patch containing propranolol by design of experiments","volume":"40","author":"Cilurzo","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2020.10.033_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.xphs.2020.10.033_bib57","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/IJN.S164404","article-title":"Development and characterization of a nanoemulsion containing propranolol for topical delivery","volume":"13","author":"Zanela da Silva Marques","year":"2018","journal-title":"Int J Nanomed"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920306250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920306250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:03Z","timestamp":1758360723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920306250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022354920306250"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.10.033","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Freeze-Dried Matrices for Buccal Administration of Propranolol in Children: Physico-Chemical and Functional Characterization","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}